The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

GlaxoSmithKline

Lawmakers decry Army’s planned Zika vaccine license to Sanofi

With two-drug combo data, GSK primes for an HIV market-share steal, but don't count out Gilead